Guideline for the clinical use and dispensing of thalidomide

Leprosy Review

Volumn 68, Issue 1, 1997, Pages 61-66

  Powell, R J ^a   Gardner Medwin, J M M ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC SEDATIVE AGENT; THALIDOMIDE;

CONTRACEPTION; DRUG LABELING; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MONITORING; ELECTROPHYSIOLOGY; INFORMED CONSENT; PATIENT COMPLIANCE; PATIENT INFORMATION; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; SHORT SURVEY; TERATOGENESIS; UNITED KINGDOM;

EID: 0030937620     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19970010     Document Type: Short Survey

References (19)

1. Barley D. Is thalidomide to blame? Br Med J, 1961; 1: 130.
2. Fullerton PM, Kremer M. Neuropathy after intake of thalidomide (Distaval). Br Med J, 1961; 2: 853-858.
3. McBride WG. Thalidomide and congenital abnormalities (letter). Lancet, 1961; 2: 1358.
4. Lenz W. Thalidomide and congenital abnormalities (letter). Lancet, 1962; 1: 45.
5. The Medicines Act 1968. HMSO, London, 1968.
6. The Medicines (Exemption from Licences) (Special Cases and Miscellaneous Provisions) Order 1972. HMSO, London, 1972.
7. Heney D, Norfolk DR, Wheeldon J et al. Thalidomide treatment for chronic graft versus-host disease. Br J Haematol, 1991; 78: 23-27.
8. Makonkawkeyoon S, Limson-Probre RN, Moreira AL, Schauf V & Kaplan G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci USA, 1993; 90: 5974-5978.
9. Crawford CL. Use of thalidomide in leprosy (letter). Br Med J, 1991; 302: 1603-1604.
10. Hawkins DF. Thalidomide for systemic lupus erythematosus (letter). Lancet, 1992; 339: 1057.
11. Drug protest; thalidomide. The Sunday Times, 14 April 1991.
12. The Medicines (Labelling) Regulations (Regulations 11(1) (b) (i) and 11(I) (b) (ii) 1976). HMSO, London, 1976.
13. The Medicines (Exemption from Licences) (Importation) Order 1984. HMSO, London, 1984.
14. Gilliatt RW, Sears TA. Sensory action potentials in patients with peripheral nerve lesions. J Neurol Neurosurg Psych, 1958; 21: 109-118.
15. Downie AW, Scott TR. An improved technique for radial nerve conduction studies. J Neurol Neurosurg Psych, 1967; 30: 332-336.
16. Burke D, Skuse NF, Lethlean AK. Sensory conduction of the sural nerve in polyneuropathy. J Neurol Neurosurg Psych, 1974; 37: 647-652.
17. Fullerton PM, O'Sullivan DJ. Thalidomide neuropathy: a clinical electrophysiological and histological follow-up study. J Neurol Neurosurg Psych, 1968; 31: 543-551.
18. Gardner-Medwin JMM, Smith NJ, Powell RJ. Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease: the use of neurophysiological studies to detect thalidomide neuropathy. Ann Rheum Dis, 1994; 53 828-832.
19. The Medicines (Exemption from Licences) (Special and Transitional Cases) Order 1971. HMSO, London 1971.